ATE371191T1 - Die verwendung von dem a3 adenosin rezeptor als marker eines krankheitszustandes - Google Patents

Die verwendung von dem a3 adenosin rezeptor als marker eines krankheitszustandes

Info

Publication number
ATE371191T1
ATE371191T1 AT03758621T AT03758621T ATE371191T1 AT E371191 T1 ATE371191 T1 AT E371191T1 AT 03758621 T AT03758621 T AT 03758621T AT 03758621 T AT03758621 T AT 03758621T AT E371191 T1 ATE371191 T1 AT E371191T1
Authority
AT
Austria
Prior art keywords
adenosine receptor
marker
disease condition
expression level
disease
Prior art date
Application number
AT03758621T
Other languages
English (en)
Inventor
Pnina Fishman
Lea Madi
Yehuda Sara Bar
Original Assignee
Can Fite Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Can Fite Biopharma Ltd filed Critical Can Fite Biopharma Ltd
Application granted granted Critical
Publication of ATE371191T1 publication Critical patent/ATE371191T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03758621T 2002-10-22 2003-10-21 Die verwendung von dem a3 adenosin rezeptor als marker eines krankheitszustandes ATE371191T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42003802P 2002-10-22 2002-10-22

Publications (1)

Publication Number Publication Date
ATE371191T1 true ATE371191T1 (de) 2007-09-15

Family

ID=32176505

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03758621T ATE371191T1 (de) 2002-10-22 2003-10-21 Die verwendung von dem a3 adenosin rezeptor als marker eines krankheitszustandes

Country Status (7)

Country Link
US (1) US20040137477A1 (de)
EP (1) EP1554583B1 (de)
JP (1) JP2006503574A (de)
AT (1) ATE371191T1 (de)
AU (1) AU2003274648A1 (de)
DE (1) DE60315863T2 (de)
WO (1) WO2004038419A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1766060A4 (de) * 2004-05-14 2007-11-28 King Pharmaceuticals Res & Dev Verfahren zur diagnose und prognostizierung von soliden tumoren und melanom
US20080051365A1 (en) * 2004-12-02 2008-02-28 Can-Fite Biopharma Ltd. Treatment of Inflammation
DK1817079T3 (da) 2004-12-02 2008-11-17 Can Fite Biopharma Ltd Behandling af inflammationer
WO2007063539A1 (en) * 2005-11-30 2007-06-07 Can-Fite Biopharma Ltd. Therapeutic uses of a3 adenosine receptor antibodies
CN101410114B (zh) 2006-01-26 2012-07-04 美国政府卫生与公共服务部 A3腺苷受体别构调节剂
WO2008056361A1 (en) * 2006-11-09 2008-05-15 Can-Fite Biopharma Ltd. A biological marker for psoriasis
CN101646685B (zh) 2007-03-14 2014-12-17 坎-菲特生物药物有限公司 合成ib-meca的方法
KR20110053434A (ko) * 2008-08-19 2011-05-23 유니버시테이트 라이덴 Ａ３ 아데노신 수용체 알로스테릭 조절인자

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543291A (en) * 1993-01-29 1996-08-06 Dana Farber Cancer Institute Method of detecting carcinoma
US6063376A (en) * 1995-01-13 2000-05-16 Human Genome Sciences, Inc. Human deoxycytidine kinase 2
EP0906448B1 (de) * 1996-04-05 2009-02-25 Antonio Giordano Methoden zur diagnose und prognose von krebs
AU4980999A (en) * 1998-07-10 2000-02-01 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The A3 adenosine receptor antagonists
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
IL133680A0 (en) * 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist

Also Published As

Publication number Publication date
DE60315863T2 (de) 2008-05-15
EP1554583B1 (de) 2007-08-22
EP1554583A1 (de) 2005-07-20
AU2003274648A1 (en) 2004-05-13
JP2006503574A (ja) 2006-02-02
DE60315863D1 (de) 2007-10-04
WO2004038419A1 (en) 2004-05-06
US20040137477A1 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
DE602006012816D1 (de) Tifizierung von zellulären folat vitamin rezeptoren
TW200710705A (en) Touch location determination using bending mode sensors and multiple detection techniques
ATE426662T1 (de) Feedback resistante mevalonate kinase
CY1110116T1 (el) Νευροεκφυλιστικοι δεικτες για καταθλιψη
ATE271691T1 (de) Verfahren zum nachweis der effektivität einer krebstherapie
NO20084354L (no) Fremgangsmate og system for styring av boreretning ved bruk av retningsfolsomme resistivitetsmalinger
DE602005024268D1 (de) System und verfahren zum operieren in einem virtuellen 3d-raum
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
ATE371191T1 (de) Die verwendung von dem a3 adenosin rezeptor als marker eines krankheitszustandes
ATE391284T1 (de) Verwendung von oberflächenmesssonden
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
EA200600197A1 (ru) Получение производных соединения 1,3-дифенилпроп-2-ен-1-он
ATE403656T1 (de) Xanthinderivate als a2b- adenosinrezeptorantagonisten
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
BRPI0408884A (pt) método para determinar propriedades de um corpo sedimentário a partir da espessura e da distribuição de tamanho de grão em um ponto dentro do corpo
ATE365327T1 (de) Verfahren zum nachweis von zelltod mittels cytochrom c.
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DK1604203T3 (da) Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter
DK1791973T3 (da) DOT1-histonmethyltransferaser som et target til at identificere terapeutiske midler mod leukæmi
WO2006105949A3 (de) Verfahren zur ermittlung der belegung eines raumes
WO2006017748A3 (en) Materials and methods for identifying anti-schizophrenic agents
WO2005002414A3 (en) Prognosis determination in ewing sarcoma patients by means of genetic profiling
DK0646182T3 (da) Fremgangsmåde til påvisning af neoplastiske sygdomme
ATE466958T1 (de) Klassifizierung von kolonkrebs
MXPA03012062A (es) Metodo para realizar el analisis de conectividad sobre base-objeto en volumenes tridimensionales de datos sismicos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties